Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin Oconnor currently holds 58,275 shares of ALBANY MOLECULAR RESEARCH INC (AMRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Oconnor has been a net seller of AMRI stock. They have purchased $28.2K and sold $163.2K worth of shares.
Kevin Oconnor's most recent insider trade was on Aug 31, 2017, when they sold 58,275 shares at $21.75 per share.
Kevin Oconnor serves as Executive at ALBANY MOLECULAR RESEARCH INC (AMRI). They have executed 24 insider transactions totaling $191.3K over their tenure at the company.
Kevin Oconnor holds the position of Executive at ALBANY MOLECULAR RESEARCH INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Kevin Oconnor has shown a selling trading pattern, with $28.2K in total purchases and $163.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kevin Oconnor was on Aug 31, 2017, when they sold $1.3M worth of AMRI shares. This transaction involved 58,275 shares at $21.75 per share.
Kevin Oconnor currently owns 58,275 shares of ALBANY MOLECULAR RESEARCH INC (AMRI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin Oconnor's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin Oconnor has 24 Form 4 filings on record as an insider at ALBANY MOLECULAR RESEARCH INC.
Set alerts for Kevin Oconnor and 40,000+ other insiders.